glp 1 oral meds New research shows a new, GLP-1 pill may be just as beneficial to those with Type 2 diabetes as injectable GLP-1 drugs Eli Lilly Captures 60% MCF Frequency:3 month supply (3 bottles)

glp 1 oral meds New research shows a new, GLP-1 pill may be just as beneficial to those with Type 2 diabetes as injectable GLP-1 drugs Eli Lilly Captures 60% MCF Frequency:3 month supply (3 bottles)

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Time of day for administration can be based on personal preference and schedule

MCF

Frequency:3 month supply (3 bottles)

1,4 Safety, Tolerability, and Counseling Considerations The most common adverse events in TRANSCEND-T2D-1 were nausea (up to 26.5%), diarrhea (up to 22.8%), and vomiting (up to 17.6%), occurring primarily during the dose escalation period and consistent with the tolerability profile of other incretin-based therapies